COVID-19

A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.

A deletion in the genome of SARS-CoV-2 variants makes resulting infections milder and could also be a target for future COVID-19 treatments.

A head-to-head test of three common mask decontamination methods helps frame standardised national guidelines.

New self-cleaning surfaces created by A*STAR researchers take inspiration from cicada wings to attract and destroy microbes without harsh chemicals.

A*STAR researchers blend the physics of particle dynamics with complex computational simulations to gauge the risk of catching COVID-19 in different social settings.

A*STAR researchers develop a standardised, self-administered taste and smell test for detecting the early symptoms of COVID-19.

Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.

A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.

A computational model developed at A*STAR provides insights on how molecular dynamics of proteins impact their function, unlocking new precision medicine opportunities.

By identifying the best way to decontaminate N95 masks, A*STAR scientists are helping solve the environmental consequences of disposable masks.

A*STAR scientists uncover surprising truths behind biodegradable face masks, prompting the need for greener alternatives.

Research reveals the safety of mRNA COVID-19 vaccines for breastfeeding mothers and the potential of passing immune protection to the baby.